Engineers Gate Manager LP V Tv Therapeutics Inc. Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.39 - $0.84 $58 - $125	-149 Reduced 0.95%	15,590 $12,000
Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.69 $40 - $72	-43 Reduced 0.27%	15,739 $16,000
Q3 2021 Nov 15, 2021	SELL	$1.53 - $2.22 $14,493 - $21,030	-9,473 Reduced 37.51%	15,782 $24,000
Q2 2021 Aug 16, 2021	SELL	$2.27 - $3.44 $18,997 - $28,789	-8,369 Reduced 24.89%	25,255 $58,000
Q1 2021 May 17, 2021	SELL	$1.97 - $2.89 $2,192 - $3,216	-1,113 Reduced 3.2%	33,624 $95,000

Q4 2020 Feb 16, 2021	BUY	$1.49 - $3.1 $51,758 - $107,684	34,737 New	34,737 $65,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.